from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3497c/mce4C

LFCtreatmentdescriptionclass of inhibitor

-1.601

Amikacinug/mL Amikacintranslation

-1.572

Cap5-10ug/mL Capreomycintranslation

-2.572

Rox10-50 ug/mL Roxithromycintranslation

-0.586

SM2-5 ug/mL Streptomycintranslation

-2.829

Tet5-10 ug/mL Tetracyclinetranslation

0.012

Rif0.2-5ug/mL Rifampicintranscription

1.183

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.714

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.087

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.197

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.128

Clofazimine10-13 ug/mL Clofaziminerespiration

1.200

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.644

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.036

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.132

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.044

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.535

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.311

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.977

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.001

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.336

KCN5-20 ug/mL Potassium cyaniderespiration

0.978

NaN30.2-2 mM Sodium aziderespiration

0.113

Nigericin50 uM Nigericinrespiration

-0.678

TRC10-150 ug/mL Triclosanrespiration

-0.284

TRZ10-25 ug/mL Thioridazinerespiration

-1.540

Valinomycin0.5-10 uM Valinomycinrespiration

1.206

ZnSO42 mM ZnSO4respiration

-0.513

menadione6-10 ug/mL Menadionerespiration

-0.080

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.344

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.790

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.233

NRP_1Non-replicating persistence stage 1dosRassociated

0.312

Amp0.2mg/mL AmpicillincellWall

0.119

Cephalexin20-100 ug/mL CephalexincellWall

0.062

Cerulenin0.32-5 ug/mL CerulenincellWall

0.017

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.329

EMB10-20 ug/mL EthambutolcellWall

1.046

Eta12-40 ug/mL EthionamidecellWall

0.821

INH0.2-0.4 ug/mL IsoniazidcellWall

0.620

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.586

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.097

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.213

BZA0.12 mg/mL BenzamidearomaticAmides

-0.242

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.344

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.724

H2O24 mM hydrogen peroxideDNAdamaging

-0.072

Levo10 ug/mL LevofloxacinDNAdamaging

-0.501

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.702

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.445

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.450

UVUV-irradiationDNAdamaging

0.588

ARP41-4 ug/mL Antitubercular compound ARP4?

0.771

Antimycin12.5-50 ug/mL Antimycin A?

0.361

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.947

PA_110-50 ug/mL Antitubercular compound PA-1?

1.242

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.155

PA8240.2-2 ug/mL PA-824?

-1.708

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.622

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.530

Verapamil50 uM Verapamil?

0.740

mercaptoethanol2 mM 2-Mercaptoethanol?

0.416

methoxatin10-20 ug/mL Methoxatin?